TAO Synergies Inc.
TAOXNASDAQHealthcare● Active
$3.85
+$0.04(+1.05%)
Market Cap$12652578
P/E Ratio—
52W High$11.98
52W Low$3.23
TAO Synergies Inc.（TAOX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · TAOX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.30M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.30M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.32M | $1.60M | $1.97M | $6.32M | $4.34M |
| G&A Expenses | $9.02M | $5.21M | $6.34M | $9.81M | $8.28M |
| Total Operating Expenses | $9.35M | $6.81M | $8.31M | $16.13M | $12.62M |
| Operating Income | ($9.05M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.44M | $1.28M | $1.65M | $0.34M | $0.01M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($28.74M) | ($12.77M) | ($6.04M) | ($5.57M) | ($12.61M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($28.74M) | ($12.77M) | ($6.04M) | ($5.57M) | ($12.61M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-8.81 | $0.00 | $-29.56 | $-20.25 | $-62.75 |
| Wtd Avg Shares | 3.30M | 0.00M | 0.47M | 0.28M | 0.20M |
| EBITDA | ($9.04M) | ($6.81M) | ($8.31M) | ($16.13M) | ($12.61M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解TAO Synergies Inc.
关于TAO Synergies Inc.（TAOX）损益表
TAO Synergies Inc.（TAOX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，TAOX实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.03B)（净利率-9609.23%）。
常见问题
TAOX · 4 问TAO Synergies Inc.（TAOX）2025财年营收为$0.00B，同比up—%。
TAOX revenueTAOX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09